American Diabetes Association® Awards $3.25 Million for Innovative Diabetes Research
Both will receive $1.625 million dollars over a five-year grant term to support breakthroughs in basic science, clinical science, technology, care and potential cures in the field of diabetes.
CardioFocus Announces U.S. FDA PMA Supplement Submission For The Breakthrough HeartLight X3 Endoscopic Ablation System
The HeartLight X3 System by CardioFocus is a next-generation AFib ablation technology, building upon the advanced features of the HeartLight Endoscopic Ablation System.
EVO Implantable Lens US Clinical Trial is Underway: Announces STAAR Surgical
STAAR Surgical advsies the investigational study, “A Multicenter Clinical Evaluation of the EVO/EVO+ Visian® Implantable Collamer® Lens,” will be conducted at more than a dozen ophthalmology clinics across the United States.
Orthofix Medical Announces Agreement to Acquire FITBONE Limb Lengthening System
Orthofix Medical advises the terms of the agreement include $18 million in cash closing consideration and a manufacturing supply contract with Wittenstein SE.
Bactiguard Makes its First Acquisition by Acquiring Vigilenz
Bactiguard deepens the partnership that was initiated in 2015 by acquiring Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz) in Malaysia. The acquisition strengthens Bactiguard’s position in infection control and wound management, as well as innovation and product development capability and capacity. The consideration consists of a cash payment of USD 4.5 million payable at closing and, subject to approval by the annual general meeting of shareholders (AGM), 241 512 new class B-shares in Bactiguard, equivalent to a value of USD 2 million.